HEMATOLOGIC NEOPLASMS Flashcards
Comprises 5% AML
[2]
FAB M0 Actue Myeloid Leukemia, Minimally Differentiated
FAB M3 Acute Promyelocytic Leukemia
FAB M0 [AML, MINIMALLY DIFFERENTIATED]
[+/-] AUER RODS
NEGATIVE
NEGATIVE MPO, SBB
FAB M0
IMMUNIPHENOTYPING: CD13, CD33, CD34,117
M0 AML, MIN. DIFFERENTIATED
M1 AML, W/O MATURATION
M2 AML, W/ MATURATION
NO CELLULAR MATURATION EVIDENCE
AML, MIN. DIFFERENTIATED M0
> 90% MYELOBLASTS
</> 10% LEUKOCYTES SHOW MATURATION TO THE PROMYELOCYTE STAGE
ACUTE MYELOID LEUKEMIA, W/O MATURATION
PRESENCE OF AUER RODS
PRESENCE OF AUER RODS [BUNDLES-FAGGOT CELLS]
FAB M1 AML, MIN. DIFFERENTIATED
FAB M2 AML, W/O MATURATION
FAB M4 ACUTE MONOMYELOCYTIC LEUKEMIA
FAB M3 AML, W/ MATURATION
POSITIVE FOR MPO, SBB, CAE
FAB M1 AML, W/O
FAB M2 AML, W/
FAB M3 PROMYELOCYTIC
PRESENCE OF CHLOROMA (green appearance of tissue using MPO)
FAB M1 W/O
ACCOUNTS FOR 50% of AML CASES
FAB M1/M2
90% MYELOBLASTS
10% MATURING NEUTRO LINEAGE
20% PRECURSORS W/ MONOCYTIC LINEAGE
FAB M2, W/
AML, W/ MATURATION [FAB M2]
genetic translocation:
t(8;21) (q22;q22.1)
RUNX1/ RUNX1T1
genetic translocation of Acute Promyelocytic Leukemia [FAB M3]
BALANCED TRANSLOCATION:
t(15;17)
PML gene - RaRa gene= PML-RaRa
+30% ABNORMAL PROMYELOCYTES
2 TYPES:
1.
associated w/ [diseases + results{
- /
[nucleus appearance]
Hypergranular
DIC +
HLA -
Hypogranular/Microgranular
“butterly” coin-on-coin appearance
FAB M3 Treatment
all-trans-retinoic acid
arsenic trioxide (ATRA)
NAEGELI’S TYPE
FAB M4
ACUTE MYELOMONOCYTIC LEUKEMIA